Heterogeneity in the Effect of Hydrocortisone in Infants Enrolled in the NICHD NRN Hydrocortisone Trial

Saturday, April 23, 2022

1:00 PM – 1:15 AM US MT

Location: Convention Center: Mile High Ballroom 3AB

CE: Enduring CME: 0.25

Publication Number: 1545.1

Samuel Gentle, UAB, Birmingham, AL, United States; Matthew Rysavy, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; lei li, RTI, Raleigh, NC, United States; Matthew Laughon, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States; Ravi M. Patel, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States; Erik A. Jensen, Children's Hospital of Philadelphia, haddonfield, NJ, United States; Susan R. Hintz, Stanford University School of Medicine, Palo Alto, CA, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; Waldemar A. Carlo, University of Alabama at Birmingham, Birmingham, AL, United States; Kristi L. Watterberg, University of New Mexico School of Medicine, Albuquerque, NM, United States

Presenting Author(s)

Samuel Gentle, MD
Assistant Professor
UAB
Birmingham, Alabama, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Samuel Gentle, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Matthew A. Rysavy, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

lei li, Ph.D: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Matthew Laughon, MD, MPH: ● Bayer (Ended In the Past 24 Months) (Products/Services: Consultant).
● I-ACT (Currently Ongoing) (Products/Services: Consultant).

Ravi M. Patel, MD, MSc: ● Infant Bacterial Therapeutics / Premier Research (Currently Ongoing) (Products/Services: Consultant).

Erik A. Jensen, MD, MSCE: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Susan R. Hintz, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Namasivayam Ambalavanan, MBBS MD: ● ProvePharm (Currently Ongoing) (Products/Services: Consultant).
● Radiometer (Currently Ongoing) (Products/Services: Consultant).
● ResBiotic (Currently Ongoing) (Products/Services: Advisory Committee).
● Shire (Currently Ongoing) (Products/Services: Consultant).

Waldemar A. Carlo, MD: ● Mednax (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).

Kristi L. Watterberg, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.